TY - JOUR
T1 - Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged fischer 344 rats
AU - Hebert, Meleik A.
AU - Gerhardt, Greg A.
PY - 1997/8
Y1 - 1997/8
N2 - To investigate the efficacy of glial cell line-derived neurotrophic factor (GDNF) in the augmentation of functional dopaminergic (DAergic) indices in aged rats, 24-month-old Fischer 344 (F344) rats received single intranigral injections of 10 μg GDNF (in 10 μ1 phosphate-buffered saline) or 10 μl phosphate-buffered saline. In locomotor activity tests, the GDNF- treated animals exhibited significant increases in both total distance traveled and movement speed compared with the vehicle group, 3 weeks after injections. In vivo microdialysis studies showed that basal extracellular levels of dopamine (DA) and its metabolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid, were significantly increased in the striatum of the GDNF-treated rats. In addition, both potassium- (100 mM, K+) and d- amphetamine (250 μM)-induced DA overflow were augmented in the striatum and nucleus accumbens of the aged rats injected with GDNF. Whole-tissue levels of DA and DA metabolites, as measured by high-performance liquid chromatography coupled with electrochemical detection, in the nucleus accumbens and substantia nigra were also elevated after GDNF administration. These results indicate that a single intranigral injection of GDNF is capable of augmenting locomotor behavior and DAergic function in the aged rat striatum and nucleus accumbens. This is the first report to demonstrate that a single intranigral injection of GDNF can improve the functional capacity of DAergic neurons of aged F344 rats.
AB - To investigate the efficacy of glial cell line-derived neurotrophic factor (GDNF) in the augmentation of functional dopaminergic (DAergic) indices in aged rats, 24-month-old Fischer 344 (F344) rats received single intranigral injections of 10 μg GDNF (in 10 μ1 phosphate-buffered saline) or 10 μl phosphate-buffered saline. In locomotor activity tests, the GDNF- treated animals exhibited significant increases in both total distance traveled and movement speed compared with the vehicle group, 3 weeks after injections. In vivo microdialysis studies showed that basal extracellular levels of dopamine (DA) and its metabolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid, were significantly increased in the striatum of the GDNF-treated rats. In addition, both potassium- (100 mM, K+) and d- amphetamine (250 μM)-induced DA overflow were augmented in the striatum and nucleus accumbens of the aged rats injected with GDNF. Whole-tissue levels of DA and DA metabolites, as measured by high-performance liquid chromatography coupled with electrochemical detection, in the nucleus accumbens and substantia nigra were also elevated after GDNF administration. These results indicate that a single intranigral injection of GDNF is capable of augmenting locomotor behavior and DAergic function in the aged rat striatum and nucleus accumbens. This is the first report to demonstrate that a single intranigral injection of GDNF can improve the functional capacity of DAergic neurons of aged F344 rats.
UR - http://www.scopus.com/inward/record.url?scp=0030854870&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030854870&partnerID=8YFLogxK
M3 - Article
C2 - 9262339
AN - SCOPUS:0030854870
SN - 0022-3565
VL - 282
SP - 760
EP - 768
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 2
ER -